v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net sales $ 115,800 $ 135,143
Cost of sales (85,609) (92,725)
Gross profit 30,191 42,418
Operating expenses    
Selling, general and administrative (26,628) (29,469)
Research, product development and regulatory (5,682) (5,706)
Transformation (2,191) (1,152)
Operating (loss) income (4,310) 6,091
Change in fair value of an equity investment 0 638
Interest expense, net (3,765) (3,693)
(Loss) income before provision for income taxes (8,075) 3,036
Income tax expense (387) (1,484)
Net (loss) income $ (8,462) $ 1,552
Net (loss) income per common share-basic $ (0.3) $ 0.06
Net (loss) income per common share-assuming dilution $ (0.3) $ 0.06
Weighted average shares outstanding—basic 28,271 27,844
Weighted average shares outstanding—assuming dilution 28,271 28,128